Atom Investors’s BioNTech BNTX Stock Holding History

Atom Investors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,804	Closed	-$443K	–	497
2024 Q1	$443K	Buy	+4,804	New	+$461K	0.06%	351

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atom Investors's BNTX Position: Q2 2024 in Review

Atom Investors sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 4,804 shares — an estimated $443K sold.

Atom Investors first reported a position in BNTX in Q1 2024 and held it in 1 quarter. The position peaked at $443K in Q1 2024. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

Atom Investors reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
Atom Investors sold 4,804 BioNTech shares in Q2 2024, an estimated $443K.
Atom Investors first reported a position in BioNTech in Q1 2024 and held it in 1 quarter.
Atom Investors's BioNTech position peaked at $443K in Q1 2024.
286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Atom Investors's 13F filing for Q2 2024, filed 14 Aug 2024.